Calamos Advisors’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,500,000
Closed -$17.2M 947
2024
Q3
$17.2M Hold
1,500,000
0.07% 298
2024
Q2
$16.9M Hold
1,500,000
0.08% 276
2024
Q1
$16.7M Hold
1,500,000
0.08% 293
2023
Q4
$16.4M Hold
1,500,000
0.08% 290
2023
Q3
$16.2M Hold
1,500,000
0.08% 289
2023
Q2
$16M Hold
1,500,000
0.08% 304
2023
Q1
$15.7M Hold
1,500,000
0.08% 306
2022
Q4
$15.4M Buy
+1,500,000
New +$15.2M 0.07% 318

Other funds holding RENE

Calamos Advisors's RENE Position: Q4 2024 in Review

Calamos Advisors sold out of Cartesian Growth Corp II (RENE) in Q4 2024, closing a stake of 1,500,000 shares — an estimated $17.2M sold.

Calamos Advisors first reported a position in RENE in Q4 2022 and held it in 8 quarters. The position peaked at $17.2M in Q3 2024. 19 funds tracked by Wall St. Rank hold RENE as of Q4 2024.

  • Calamos Advisors reported no remaining Cartesian Growth Corp II position as of Q4 2024 after selling out during the quarter.
  • Calamos Advisors sold 1,500,000 Cartesian Growth Corp II shares in Q4 2024, an estimated $17.2M.
  • Calamos Advisors first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 8 quarters.
  • Calamos Advisors's Cartesian Growth Corp II position peaked at $17.2M in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2024.

Based on Calamos Advisors's 13F filing for Q4 2024, filed 24 Jan 2025.